Moreover, in our in vitro experimental setting, the p53 pathway and genes related to ER stress (e.g., ATF3) were downregulated by AAT, suggesting that AAT may be involved in modulating these biological responses in CMT1A as well. The gene discussed is SERPINA1; the disease is Charcot-Marie-Tooth disease type 1A.